Year in Review 2020: COPD

Inhaled Corticosteroid Therapy May Reduce Lung Function Decline in COPD

Revefenacin Plus Formoterol Via Nebulization Improves Lung Function Response in COPD

ATS: Clinical Practice Guidelines on the Pharmacologic Management of COPD

Antiplatelet Therapy in COPD May Reduce All-Cause Mortality, Improve QoL

Oral Sustained-Release Morphine May Improve Moderate, Severe Breathlessness in COPD

First-in-Class Dual PDE Inhibitor Plus Tiotropium May Improve Lung Function in COPD

Breztri Aerosphere Approved as Triple-Combination Therapy Inhaler for COPD

ProAir Digihaler, a Rescue Inhaler With Built-In Sensors, Now Available

Combined Long-Acting Bronchodilator Therapy Compared With Monotherapy for COPD

Digital Health Tool Propeller Cleared for Use With Symbicort Inhaler

COPD Maintenance Therapy: Adverse Outcomes With Tiotropium/Olodaterol vs LABA/ICS

Risk for Severe COVID-19 May Be Up in People With COPD, Smokers

GATA3 Innate Lymphoid Cells Associated With Sputum Eosinophilia in COPD

Antibiotics, Corticosteroids Beneficial in COPD Exacerbations